What will the phase 3 clinical trial results report for vaccine efficacy (%) of the R21 malaria vaccine at 48 months?
Health & MedicineOne-Off10mo
Manifold MarketsNo KYCVerified resolution dataFairly calibratedCurrent community forecast60-69% 25.6%Leader of 7 outcomes
Forecasters
14
Question type
multiple choice
Methodology
Play-money forecasting platform
Source type
Forecast
7d Change
0.0 pts
Market data
Updated 9 hours ago
StaleMar 15, 24, 9:29 PM UTCSep 2, 27, 6:59 AM UTC
Trends
Related Markets
Related questions for context, not a comparison of equivalent contracts.
What will the phase 3 clinical trial results report for vaccine efficacy (%) of the R21 malaria vaccine at 24 months?
Manifold MarketsWill molecular jackhammers have at least 50% tumour-free efficacy in Phase 2 clinical trials?
Manifold MarketsSkin cancer vaccine BLA submitted by which date?
PolymarketIs Cheryl Scott from ABC CHICAGO pregnant????!?!??? 🤰
Manifold MarketsAnthropic lab leak by which date?
PolymarketHantavirus pandemic in 2026? [Polymarket]
Manifold MarketsRules
The 12 month phase 3 data indicates 75% vaccine efficacy of R21 in annual malaria sites in children at 12 months after the first dose was delivered.
- Phase 2b data at a 42 month timepoint showed 71% efficacy after four total doses (Abstract here, #6949).
- Resolves upon publication of peer-reviewed data from the R21 team at Oxford (expected to be before September 1st, 2026).
- Vaccine efficacy is defined as the primary endpoint for time to clinical malaria in seasonal sites, as defined in the paper linked above.
- 1Day Sooner has an R21 Status Report available here that may be useful.
- More malaria-related questions can be found on our Manifold account here.
